Titan Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TITAN PHARMS, and what generic alternatives to TITAN PHARMS drugs are available?
TITAN PHARMS has one approved drug.
There is one US patent protecting TITAN PHARMS drugs.
There are thirteen patent family members on TITAN PHARMS drugs in thirteen countries.
Drugs and US Patents for Titan Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Titan Pharms | PROBUPHINE | buprenorphine hydrochloride | IMPLANT;IMPLANTATION | 204442-001 | May 26, 2016 | DISCN | Yes | No | 7,736,665 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Titan Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2005528422 | ⤷ Try a Trial |
Mexico | PA04011875 | ⤷ Try a Trial |
European Patent Office | 2561860 | ⤷ Try a Trial |
Portugal | 2561860 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.